• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性氯胺酮滥用者的认知障碍。

Cognitive impairment in chronic ketamine abusers.

机构信息

Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangzhou, China.

Hunan Key Laboratory of Psychiatry and Mental Health, Department of Psychiatry & Mental Health Institute of the Second Xiangya Hospital, National Clinical Research Center on Mental Disorders & National Technology Institute on Mental Disorders, Central South University, Changsha, China.

出版信息

Psychiatry Res. 2020 Sep;291:113206. doi: 10.1016/j.psychres.2020.113206. Epub 2020 Jun 8.

DOI:10.1016/j.psychres.2020.113206
PMID:32763531
Abstract

BACKGROUND

The treatment of ketamine users is substantially challenged by high dropout rates, raising questions regarding contributing factors. A number of studies have highlighted the potential of greater focus on the clinical significance of cognitive impairments in ketamine users. The present study hypothesized that cognitive deficits would play a role in greater risk for treatment dropout in chronic ketamine users.

METHODS

Our study examined cognitive performance in the form of working memory, verbal memory, visual memory and executive function among chronic ketamine users who completed three-month treatment in residential detoxification centres (N = 165), those who dropped out prematurely (N = 121) and drug-free healthy controls (N = 111). The data collection was completed in Hong Kong among the East Asia population.

RESULTS

Compared to healthy controls, cognitive impairments were found in ketamine users, including in verbal/visual memory and executive function. Executive dysfunction was significantly associated with dropout in ketamine users within three months.

CONCLUSION

Our findings suggest that executive dysfunction may have clinical benefits in ketamine users admitted to residential treatment programmes.

摘要

背景

由于较高的脱落率,氯胺酮使用者的治疗受到了极大的挑战,这引发了对促成因素的质疑。许多研究都强调了更加关注氯胺酮使用者认知障碍的临床意义的重要性。本研究假设认知缺陷会导致慢性氯胺酮使用者治疗脱落的风险增加。

方法

我们的研究通过工作记忆、言语记忆、视觉记忆和执行功能检查,对在住院戒毒中心完成三个月治疗的慢性氯胺酮使用者(N=165)、提前脱落的患者(N=121)和无毒品的健康对照组(N=111)进行了研究。数据采集在东亚人群的香港进行。

结果

与健康对照组相比,氯胺酮使用者存在认知障碍,包括言语/视觉记忆和执行功能障碍。在三个月内,执行功能障碍与氯胺酮使用者的脱落显著相关。

结论

我们的研究结果表明,在接受住院治疗的氯胺酮使用者中,执行功能障碍可能具有临床意义。

相似文献

1
Cognitive impairment in chronic ketamine abusers.慢性氯胺酮滥用者的认知障碍。
Psychiatry Res. 2020 Sep;291:113206. doi: 10.1016/j.psychres.2020.113206. Epub 2020 Jun 8.
2
Other drug use does not impact cognitive impairments in chronic ketamine users.其他药物使用不会影响慢性氯胺酮使用者的认知障碍。
Drug Alcohol Depend. 2018 May 1;186:1-8. doi: 10.1016/j.drugalcdep.2018.01.007. Epub 2018 Feb 27.
3
Cognitive impairments in poly-drug ketamine users.多药滥用氯胺酮使用者的认知障碍。
Addict Behav. 2013 Nov;38(11):2661-6. doi: 10.1016/j.addbeh.2013.06.017. Epub 2013 Jun 28.
4
The profile of cognitive impairments in chronic ketamine users.慢性氯胺酮使用者的认知功能障碍特征。
Psychiatry Res. 2018 Aug;266:124-131. doi: 10.1016/j.psychres.2018.05.050. Epub 2018 May 26.
5
The impact of depressive symptoms on cognitive impairments in chronic ketamine users.抑郁症状对慢性氯胺酮使用者认知障碍的影响。
Compr Psychiatry. 2024 Feb;129:152448. doi: 10.1016/j.comppsych.2023.152448. Epub 2023 Dec 27.
6
Relationship between cognitive impairment and depressive symptoms in current ketamine users.当前氯胺酮使用者认知障碍与抑郁症状的关系。
J Stud Alcohol Drugs. 2013 May;74(3):460-8. doi: 10.15288/jsad.2013.74.460.
7
Recovery of cognitive functioning following abstinence from ketamine.从氯胺酮戒断后认知功能的恢复。
Addict Behav. 2019 Dec;99:106081. doi: 10.1016/j.addbeh.2019.106081. Epub 2019 Aug 7.
8
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.慢性氯胺酮自我给药对神经认知功能和心理健康的影响:一项为期 1 年的纵向研究。
Addiction. 2010 Jan;105(1):121-33. doi: 10.1111/j.1360-0443.2009.02761.x. Epub 2009 Nov 17.
9
Ketamine use: a review.氯胺酮的使用:综述。
Addiction. 2012 Jan;107(1):27-38. doi: 10.1111/j.1360-0443.2011.03576.x. Epub 2011 Jul 22.
10
Effects of chronic ketamine use on frontal and medial temporal cognition.慢性氯胺酮使用对额颞叶和内侧颞叶认知的影响。
Addict Behav. 2013 May;38(5):2128-32. doi: 10.1016/j.addbeh.2013.01.014. Epub 2013 Jan 31.

引用本文的文献

1
Widespread reductions in cortical thickness following ketamine abuse.广泛的皮质厚度减少后,滥用氯胺酮。
J Psychiatry Neurosci. 2024 May 30;49(3):E182-E191. doi: 10.1503/jpn.230111. Print 2024 May-Jun.
2
Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system.全脑图谱揭示了氯胺酮对多巴胺系统的不同影响。
Cell Rep. 2023 Dec 26;42(12):113491. doi: 10.1016/j.celrep.2023.113491. Epub 2023 Dec 4.
3
Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial.
重复剂量艾司氯胺酮对患有重度抑郁症和自杀意念的青少年的短期认知影响:一项随机对照试验。
Child Adolesc Psychiatry Ment Health. 2023 Sep 14;17(1):108. doi: 10.1186/s13034-023-00647-2.
4
Higher glutamatergic activity in the medial prefrontal cortex in chronic ketamine users.慢性氯胺酮使用者的内侧前额叶皮质谷氨酸能活性升高。
J Psychiatry Neurosci. 2022 Jul 26;47(4):E263-E271. doi: 10.1503/jpn.210179. Print 2022 Jul-Aug.
5
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.超越拉斯金方案:难治性慢性偏头痛的氯胺酮、利多卡因和其他疗法。
Curr Pain Headache Rep. 2021 Dec 11;25(12):77. doi: 10.1007/s11916-021-00992-x.
6
Test-retest reliability and cross-cultural applicability of DSM-5 adopted diagnostic criteria for ketamine use disorders.DSM-5 采用的氯胺酮使用障碍诊断标准的重测信度和跨文化适用性。
Drug Alcohol Depend. 2021 Nov 1;228:109056. doi: 10.1016/j.drugalcdep.2021.109056. Epub 2021 Sep 21.
7
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.英格兰国家药物滥用死亡计划通报的与娱乐性氯胺酮相关的死亡,1997-2019 年。
J Psychopharmacol. 2021 Nov;35(11):1324-1348. doi: 10.1177/02698811211021588. Epub 2021 Jun 5.